Andrew Ritter

Andrew Ritter is a seasoned executive with extensive experience in healthcare and biotechnology. Currently serving as the Chief Executive Officer of Cairns Health, Ritter leads the development of Luna, a digital care platform for senior living and home care. In addition, Ritter holds a board position at Myosin Therapeutics, a company focused on novel therapies targeting cellular motor proteins. Previously, Ritter was the CEO of Docbot, an AI technology firm aimed at diagnosing gastrointestinal diseases, and served as the President and CEO of Ritter Pharmaceuticals, where significant advancements in gut microbiome therapeutics were achieved. Ritter's career also includes managing Ritter Natural Sciences, driving the commercialization of digestive healthcare brands. Educational credentials include an MBA in Finance from The Wharton School and a BA in Political Science from the University of Southern California.